| abstract |
Use of: (a) a physiologically acceptable source of assimilable copper; (b) salicylic acid or a physiologically acceptable derivative thereof; (c) vitamin C; and (d) a physiologically acceptable source of assimilable zinc, in the manufacture of a medicament for the prevention or treatment of a respiratory disease, septicaemia, cellulitis, AIDS, an autoimmune disease, or a bacterial or viral infection, in particular common cold or influenza, or for enhancing the immune system. |